[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 320
Citations 0
Invited Commentary
February 2016

Predicting Factors Associated With Comorbidity Remission Following Bariatric SurgeryPreliminary Progress

Author Affiliations
  • 1George Washington University, Washington, DC
  • 2National Center for Weight and Wellness, Washington, DC
JAMA Surg. 2016;151(2):137-138. doi:10.1001/jamasurg.2015.3237

Perhaps the most reliable expectation of obesity treatment is variability. We see vast heterogeneity in treatment response to bariatric surgery, pharmacotherapy, behavioral therapy, medically and self-directed weight loss, and other modalities, each ranging from near-miraculous benefits to null, or even negative, effects. For example, weight loss from bariatric surgery ranges from more than 100% excess body weight loss in hyperresponders to weight gain in some nonresponders, with standard deviations often exceeding mean weight loss.1 Similarly, health outcomes range from complete resolution of comorbid conditions and life-changing improvements in quality of life to tragic adverse events, including addiction, disability, and suicide.25

First Page Preview View Large
First page PDF preview
First page PDF preview
×